tiprankstipranks
Trending News
More News >
Evolutionary Genomics (FNAM)
:FNAM
US Market
Advertisement

Evolutionary Genomics (FNAM) Income Statement

Compare
1 Followers

Evolutionary Genomics Income Statement

Last quarter (Q4 2022), Evolutionary Genomics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Evolutionary Genomics's net income was $-254.77K. See Evolutionary Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 12.50K$ 122.69K$ 114.81K
Gross Profit
$ -1.02M$ -1.04M$ -1.78M$ -83.14K$ 114.81K
Operating Expenses
$ 992.81K$ 1.84M$ 1.10M$ 897.51K$ 951.61K
Depreciation and Amortization
$ 1.02M$ 1.04M$ 409.37K$ 40.72K$ 41.08K
EBITDA
$ -913.47K$ -1.76M$ -2.47M$ -734.10K$ -795.72K
Operating Income
$ -2.01M$ -2.88M$ -2.88M$ -774.83K$ -836.80K
Other Income/Expenses
$ 79.33K$ 84.00K$ 180.56K$ 13.59K$ -261.82K
Pretax Income
$ -1.93M$ -2.79M$ -2.70M$ -761.23K$ -1.10M
Net Income
$ -1.93M$ -2.79M$ -1.71M$ -793.14K$ -1.10M
Per Share Metrics
Basic EPS
$ -0.35$ -0.52$ -0.34$ -0.13$ -0.19
Diluted EPS
$ -0.35$ -0.52$ -0.34$ -0.13$ -0.19
Weighted Average Shares Outstanding
6.42M 5.88M 5.88M 5.88M 5.88M
Weighted Average Shares Outstanding (Diluted)
6.46M 5.88M 5.88M 5.88M 5.88M
Currency in USD

Evolutionary Genomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis